Diabetes treatment is constantly advancing, with new therapeutic options emerging to improve patient outcomes. Recent studies have focused on GLP-1 and GIP receptor agonists, a class of drugs that mimic the actions of https://anniedvcv630156.wikicommunications.com/6825767/novel_glp_1_and_gip_receptor_agonists_a_new_era_in_diabetes_treatment